Enteryx

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2014
02420022014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
a 2−year history of intermittant, sharp, left−sided chest pain. Two years before, the patient had had an injection of nonre… (More)
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2006
2006
Perendoscopic treatments of gastroesophageal reflux have been used in clinical practice following FDA approval of the first two… (More)
Is this relevant?
2005
2005
We describe the case of a 68-year-old female who developed pneumomediastinum following the “Enteryx” procedure for the treatment… (More)
  • figure 1
  • figure 2
Is this relevant?
2005
2005
BACKGROUND Portal vein embolization (PVE) has been used as a preoperative strategy to induce hepatic lobar atrophy and… (More)
Is this relevant?
2005
2005
BACKGROUND & AIMS This aim was to determine whether endoscopic implantation of a biocompatible nonresorbable copolymer (Enteryx… (More)
Is this relevant?
2005
2005
BACKGROUND The need is well recognized for additional data on endoluminal therapies for gastroesophageal reflux disease (GERD… (More)
Is this relevant?
2004
2004
Enteryx (Boston Scientific) is an injectable solution containing 8% ethylene vinyl alcohol copolymer dissolved in dimethyl… (More)
  • figure 1
  • figure 2
Is this relevant?
2003
2003
OBJECTIVES:This prospective, multicenter, single-arm study evaluated the safety and efficacy of the endoscopic implantation of… (More)
  • table 1
  • table 3
  • table 2
  • table 4
  • table 5
Is this relevant?
2003
2003
We investigated the feasibility, safety, and efficacy of laparoscopic antireflux surgery (LARS) after failure of Enteryx… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2002
2002
Background: Endoscopic approaches to restore the gastroesophageal barrier in patients with gastroesophageal reflux disease (GERD… (More)
Is this relevant?